Correction to: Validation of a novel western blot assay to monitor patterns and levels of alpha dystroglycan in skeletal muscle of patients with limb girdle muscular dystrophies.

Rajasingham, Thulashitha; Rodriguez, Hector M; Betz, Andreas; Sproule, Douglas M; Sinha, Uma

Rajasingham, Thulashitha; Rodriguez, Hector M; Betz, Andreas; Sproule, Douglas M; Sinha, Uma.

Afiliação

Rajasingham T; Department of Preclinical/Clinical Pharmacology, ML Bio Solutions, a BridgeBio company, Palo Alto, USA. thula.rajasingham@bridgebio.com.
Rodriguez HM; Department of Preclinical/Clinical Pharmacology, ML Bio Solutions, a BridgeBio company, Palo Alto, USA.
Betz A; Department of Preclinical/Clinical Pharmacology, ML Bio Solutions, a BridgeBio company, Palo Alto, USA.
Sproule DM; Department of Clinical Development, ML Bio Solutions, a BridgeBio company, Palo Alto, USA.
Sinha U; Department of Preclinical/Clinical Pharmacology, ML Bio Solutions, a BridgeBio company, Palo Alto, USA.

J Muscle Res Cell Motil ; 2024 Jun 24.

Article em En | MEDLINE | ID: mdl-38913101

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article